Latest News and Press Releases

TORONTO, ON, March 21, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions for the development of a blockchain platform and cryptocurrency that...

TORONTO, ON, March 14, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has commenced negotiations with an AMPR applicant towards a Canadian Marijuana cultivators /...

TORONTO, ON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals (OTC:EAPH) announces the appointment of Dr. Daniel Bagi, MD as Director, President of Business Development.  Provides other...

TORONTO, ON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions to transfer part of its licensed woman’s diagnostic and treatment...

Agreement Terms Include Several Up-Front Cash Payments Based On Milestones And A Time Limited Recurring Royalty Payment on Each Product Sold TORONTO, ON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Easton...

This Board Appointment Represents the First of Several Others to Soon be Announced TORONTO, ON, Jan. 10, 2018 (GLOBE NEWSWIRE) --  Easton Pharmaceuticals Inc. (OTC PINK: EAPH) is pleased...

TORONTO, ON, Dec. 06, 2017 (GLOBE NEWSWIRE) --  Easton Pharmaceuticals Inc. (OTC: EAPH) and its JV partner, BMV Medica SA de CV, announces product delivery and launch of its licensed AmnioSense...